Clinical trial
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
NCT00054873 is registered in ClinicalTrials.gov with Chiron Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
- Lead sponsor
- Chiron Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- December 31, 2004
- Enrollment
- Not reported
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.